M&T Bank Corp Reduces Position in Agilent Technologies, Inc. $A

Key Points

• M&T Bank Corp cut its position in Agilent Technologies by 70.0% in Q4, selling 13,225 shares and leaving it with 5,667 shares worth about $771,000.
• By contrast, several large investors materially increased stakes—Massachusetts Financial Services now owns 14,147,601 shares valued at roughly $1.925 billion, and AQR, Ameriprise, SG Americas and Lazard also made large additions.
• Analysts have trimmed price targets recently but the consensus rating remains Buy with a $163.71 average target, while the stock trades near $114.57 and Agilent slightly missed the most recent quarter’s EPS and provided FY2026 guidance of $5.90–$6.04.

M&T Bank Corp cut its position in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) by 70.0% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 5,667 shares of the medical research company's stock after selling 13,225 shares during the period. M&T Bank Corp's holdings in Agilent Technologies were worth $771,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in A. Massachusetts Financial Services Co. MA boosted its stake in shares of Agilent Technologies by 13.8% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 14,147,601 shares of the medical research company's stock worth $1,925,064,000 after purchasing an additional 1,713,216 shares during the period. AQR Capital Management LLC boosted its position in Agilent Technologies by 424.1% in the 2nd quarter. AQR Capital Management LLC now owns 2,041,826 shares of the medical research company's stock valued at $240,956,000 after buying an additional 1,652,244 shares during the period. Ameriprise Financial Inc. boosted its position in Agilent Technologies by 132.2% in the 2nd quarter. Ameriprise Financial Inc. now owns 2,354,111 shares of the medical research company's stock valued at $277,807,000 after buying an additional 1,340,161 shares during the period. SG Americas Securities LLC boosted its position in Agilent Technologies by 3,091.1% in the 4th quarter. SG Americas Securities LLC now owns 808,215 shares of the medical research company's stock valued at $109,974,000 after buying an additional 782,888 shares during the period. Finally, Lazard Asset Management LLC boosted its position in Agilent Technologies by 639.4% in the 2nd quarter. Lazard Asset Management LLC now owns 678,718 shares of the medical research company's stock valued at $80,093,000 after buying an additional 586,931 shares during the period.

Analysts Set New Price Targets

Several equities research analysts have issued reports on the stock. Barclays lowered their price objective on shares of Agilent Technologies from $150.00 to $140.00 and set an "overweight" rating for the company in a research report on Tuesday, April 14th. UBS Group lowered their price objective on shares of Agilent Technologies from $180.00 to $165.00 and set a "buy" rating for the company in a research report on Thursday, February 26th. Morgan Stanley lowered their price objective on shares of Agilent Technologies from $180.00 to $160.00 and set an "overweight" rating for the company in a research report on Tuesday, March 3rd. Wells Fargo & Company lowered their price objective on shares of Agilent Technologies from $175.00 to $165.00 and set an "overweight" rating for the company in a research report on Thursday, February 26th. Finally, TD Cowen lowered their price objective on shares of Agilent Technologies from $170.00 to $157.00 and set a "buy" rating for the company in a research report on Thursday, February 26th. Two investment analysts have rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat, Agilent Technologies has a consensus rating of "Buy" and a consensus price target of $163.71.

Agilent Technologies Price Performance

Shares of A opened at $114.57 on Friday. The company has a 50 day moving average price of $116.34 and a 200-day moving average price of $132.53. Agilent Technologies, Inc. has a fifty-two week low of $104.36 and a fifty-two week high of $160.27. The stock has a market capitalization of $32.38 billion, a PE ratio of 25.29, a PEG ratio of 2.43 and a beta of 1.22. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.59 and a current ratio of 2.07.

Agilent Technologies (NYSE:A - Get Free Report) last announced its quarterly earnings results on Wednesday, February 25th. The medical research company reported $1.36 earnings per share for the quarter, missing the consensus estimate of $1.37 by ($0.01). Agilent Technologies had a return on equity of 24.49% and a net margin of 18.26%.The business had revenue of $1.80 billion during the quarter, compared to analysts' expectations of $1.81 billion. During the same period in the previous year, the company posted $1.31 EPS. Agilent Technologies's revenue for the quarter was up 7.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. Equities analysts predict that Agilent Technologies, Inc. will post 5.95 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, April 22nd. Stockholders of record on Tuesday, March 31st were given a $0.255 dividend. This represents a $1.02 annualized dividend and a dividend yield of 0.9%. The ex-dividend date of this dividend was Tuesday, March 31st. Agilent Technologies's dividend payout ratio is presently 22.52%.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company's product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.